These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25117266)

  • 1. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.
    Engelstoft MS; Norn C; Hauge M; Holliday ND; Elster L; Lehmann J; Jones RM; Frimurer TM; Schwartz TW
    Br J Pharmacol; 2014 Dec; 171(24):5774-89. PubMed ID: 25117266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
    Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
    Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
    Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
    Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
    Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM
    Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
    Lauffer LM; Iakoubov R; Brubaker PL
    Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice.
    Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
    Biol Chem; 2014 Apr; 395(4):453-64. PubMed ID: 24323890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.
    Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG
    Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameterization of the GPR119 Receptor Agonist AR231453.
    Hamilton J; Kotsikorou E
    J Comput Chem; 2018 Jan; 39(1):35-41. PubMed ID: 29023843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.
    Chepurny OG; Bertinetti D; Diskar M; Leech CA; Afshari P; Tsalkova T; Cheng X; Schwede F; Genieser HG; Herberg FW; Holz GG
    Mol Endocrinol; 2013 Aug; 27(8):1267-82. PubMed ID: 23798572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
    Flock G; Holland D; Seino Y; Drucker DJ
    Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening.
    Norn C; Hauge M; Engelstoft MS; Kim SH; Lehmann J; Jones RM; Schwartz TW; Frimurer TM
    Structure; 2015 Dec; 23(12):2377-2386. PubMed ID: 26526849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.
    Hansen KB; Rosenkilde MM; Knop FK; Wellner N; Diep TA; Rehfeld JF; Andersen UB; Holst JJ; Hansen HS
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1409-17. PubMed ID: 21778222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
    Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
    Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
    Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
    Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.
    Arifin SA; Paternoster S; Carlessi R; Casari I; Ekberg JH; Maffucci T; Newsholme P; Rosenkilde MM; Falasca M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1132-1141. PubMed ID: 29883799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR119 as a fat sensor.
    Hansen HS; Rosenkilde MM; Holst JJ; Schwartz TW
    Trends Pharmacol Sci; 2012 Jul; 33(7):374-81. PubMed ID: 22560300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Cell Inactivation of
    Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
    Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
    Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.